The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
From conversion to aggregation: Protofibril formation of the prion protein
Open accessAbstract
The ability to diagnose and treat prion diseases is limited by our current understanding of the conversion process of the protein from healthy to harmful isoform. Whereas the monomeric, benign species is well characterized, the misfolded conformations responsible for infectivity and neurodegeneration remain elusive. There is mounting evidence that fibrillization intermediates, or protofibrils, but not mature fibrils or plaques, are the pathogenic species in amyloid diseases. Here, we use molecular dynamics to simulate the conversion of the prion protein. Molecular dynamics simulation produces a scrapie prion protein-like conformation enriched in β-structure that is in good agreement with available experimental data. The converted conformation was then used to model a protofibril by means of the docking of hydrophobic patches of the template structure to form hydrogen-bonded sheets spanning adjacent subunits. The resulting protofibril model provides a non-branching aggregate with a 3 1 axis of symmetry that is in good agreement with a wide variety of experimental data; importantly, it was derived from realistic simulation of the conversion process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10962 · Cited by 2,277
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,988
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
NMR structure of the mouse prion protein domain PrP(121–231)
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996) · Nature · doi:10.1038/382180a0 · Cited by 1,257
NMR solution structure of the human prion protein
Zahn, R., Liu, A., Lührs, T., Riek, R., von Schroetter, C., López García, F., Billeter, M., Calzolai, L., Wider, G., & Wüthrich, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.145 · Cited by 1,098
Scrapie prions aggregate to form amyloid-like birefringent rods
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F., & Glenner, G. G. (1983) · Cell · doi:10.1016/0092-8674(83)90168-x · Cited by 1,043
Ferrin, T. E., Huang, C. C., Jarvis, L. E., & Langridge, R. (1988) · Journal of Molecular Graphics · doi:10.1016/0263-7855(88)80054-7 · Cited by 950
Neurotoxicity of a prion protein fragment
Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., & Tagliavini, F. (1993) · Nature · doi:10.1038/362543a0 · Cited by 943
A protease-resistant protein is a structural component of the Scrapie prion
McKinley, M. P., Bolton, D. C., & Prusiner, S. B. (1983) · Cell · doi:10.1016/0092-8674(83)90207-6 · Cited by 917
Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P., & Prusiner, S. B. (1996) · Science · doi:10.1126/science.274.5295.2079 · Cited by 865
Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F., & Caughey, W. S. (1991) · Biochemistry · doi:10.1021/bi00245a003 · Cited by 822
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E., & Dyson, H. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13452 · Cited by 674
Levitt, M., Hirshberg, M., Sharon, R., Laidig, K. E., & Daggett, V. (1997) · The Journal of Physical Chemistry B · doi:10.1021/jp964020s · Cited by 561
Self-citationAntibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
Non-genetic propagation of strain-specific properties of scrapie prion protein
Bessen, R. A., Kocisko, D. A., Raymond, G. J., Nandan, S., Lansbury, P. T., & Caughey, B. (1995) · Nature · doi:10.1038/375698a0 · Cited by 525
Amyloid fibers are water-filled nanotubes
Perutz, M. F., Finch, J. T., Berriman, J., & Lesk, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042681399 · Cited by 506
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J., & Hawke, S. (2003) · Nature · doi:10.1038/nature01457 · Cited by 492
James, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donne, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10086 · Cited by 452
Levitt, M., Hirshberg, M., Sharon, R., & Daggett, V. (1995) · Computer Physics Communications · doi:10.1016/0010-4655(95)00049-l · Cited by 443
Self-citationVolles, M. J., & Lansbury, P. T. (2003) · Biochemistry · doi:10.1021/bi030086j · Cited by 433
Structural studies of the scrapie prion protein by electron crystallography
Wille, H., Michelitsch, M. D., Guénebaut, V., Supattapone, S., Serban, A., Cohen, F. E., Agard, D. A., & Prusiner, S. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052703499 · Cited by 420
NMR structure of the bovine prion protein
López García, F., Zahn, R., Riek, R., & Wüthrich, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8334 · Cited by 385
Blake, C., & Serpell, L. (1996) · Structure · doi:10.1016/s0969-2126(96)00104-9 · Cited by 376
Peretz, D., Williamson, R. A., Matsunaga, Y., Serban, H., Pinilla, C., Bastidas, R. B., Rozenshteyn, R., James, T. L., Houghten, R. A., Cohen, F. E., et al. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1328 · Cited by 336
Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein
Caughey, B., Raymond, G. J., & Bessen, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32230 · Cited by 318
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis
McKinley, M. P., Meyer, R. K., Kenaga, L., Rahbar, F., Cotter, R., Serban, A., & Prusiner, S. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1340-1351.1991 · Cited by 257
pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)
Swietnicki, W., Petersen, R., Gambetti, P., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27517 · Cited by 256
Li, A., & Daggett, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10430 · Cited by 247
Self-citationEtiology and pathogenesis of prion diseases.
DeArmond, S. J., & Prusiner, S. B. (1995) · Europe PMC (PubMed Central) · Cited by 243
Cellular Biology of Prion Diseases
Harris, D. A. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.3.429 · Cited by 233
Li, A., & Daggett, V. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0172 · Cited by 228
Self-citationMapping the Prion Protein Using Recombinant Antibodies
Williamson, R. A., Peretz, D., Pinilla, C., Ball, H., Bastidas, R. B., Rozenshteyn, R., Houghten, R. A., Prusiner, S. B., & Burton, D. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9413-9418.1998 · Cited by 217
McColl, I. H., Blanch, E. W., Gill, A. C., Rhie, A. G. O., Ritchie, M. A., Hecht, L., Nielsen, K., & Barron, L. D. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021464v · Cited by 202
Influence of pH on NMR Structure and Stability of the Human Prion Protein Globular Domain
Calzolai, L., & Zahn, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303005200 · Cited by 186
Local Structural Plasticity of the Prion Protein. Analysis of NMR Relaxation Dynamics
Viles, J. H., Donne, D., Kroon, G., Prusiner, S. B., Cohen, F. E., Dyson, H. J., & Wright, P. E. (2001) · Biochemistry · doi:10.1021/bi002898a · Cited by 174
Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells.
Rogers, M., Yehiely, F., Scott, M., & Prusiner, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3182 · Cited by 174
X-ray Diffraction of Scrapie Prion Rods and PrP Peptides
Nguyen, J. T., Inouye, H., Baldwin, M. A., Fletterick, R. J., Cohen, F. E., Prusiner, S. B., & Kirschner, D. A. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0507 · Cited by 169
Mapping the early steps in the pH-induced conformational conversion of the prion protein
Alonso, D. O. V., DeArmond, S. J., Cohen, F. E., & Daggett, V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061555898 · Cited by 164
Self-citationIdeas of Order for Amyloid Fibril Structure
Wetzel, R. B. (2002) · Structure · doi:10.1016/s0969-2126(02)00809-2 · Cited by 151
Evidence for the role of PrP C helix 1 in the hydrophilic seeding of prion aggregates
Morrissey, M., & Shakhnovich, E. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11293 · Cited by 131
Multiple folding pathways for heterologously expressed human prion protein
Jackson, G. S., Hill, A. F., Joseph, C., Hosszu, L. L. P., Power, A., Waltho, J. P., Clarke, A. R., & Collinge, J. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00038-2 · Cited by 125
Interactions between prion protein isoforms: the kiss of death?
Caughey, B. W. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01792-3 · Cited by 122
Kocisko, D. A., Lansbury, P. T., & Caughey, B. W. (1996) · Biochemistry · doi:10.1021/bi9610562 · Cited by 116
Salmona, M., MALESANI, P., GIOIA, L. D., GORLA, S., Bruschi, M., MOLINARI, A., VEDOVA, F. D., Pedrotti, B., MARRARI, M. A., Awan, T., et al. (1999) · Biochemical Journal · doi:10.1042/bj3420207 · Cited by 109
The Role of Helix 1 Aspartates and Salt Bridges in the Stability and Conversion of Prion Protein
Speare, J. O., Rush, T. S., Bloom, M. E., & Caughey, B. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211599200 · Cited by 97
Schwarz, A., Krätke, O., Burwinkel, M., Riemer, C., Schultz, J., Henklein, P., Bamme, T., & Baier, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00907-8 · Cited by 96
Laws, D. D., Bitter, H. L., Liu, K., Ball, H. L., Kaneko, K., Wille, H., Cohen, F. E., Prusiner, S. B., Pines, A., & Wemmer, D. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201404298 · Cited by 79
Vanik, D. L., & Surewicz, W. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207511200 · Cited by 73
Horiuchi, M., Baron, G. S., Xiong, L., & Caughey, B. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100288200 · Cited by 70
CD and NMR Studies of Prion Protein (PrP) Helix 1
Ziegler, J., Sticht, H., Marx, U., Müller, W., Rösch, P., & Schwarzinger, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305234200 · Cited by 66
Cited by
Molecular dynamics simulations and novel drug discovery
Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1403419 · Cited by 518
Implications of peptide assemblies in amyloid diseases
Ke, P. C., Sani, M.-A., Ding, F., Kakinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338
Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure
Cobb, N. J., Sönnichsen, F. D., Mchaourab, H., & Surewicz, W. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706522104 · Cited by 326
Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions
Caughey, B., Baron, G. S., Chesebro, B., & Jeffrey, M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145410 · Cited by 323
The Yin and Yang of protein folding
Jahn, T. R., & Radford, S. E. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.05021.x · Cited by 323
Metadata
- Authors
- DeMarco, M. L., & Daggett, V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-02-13
- Volume
- 101
- Issue
- 8
- Pages
- 2293-2298
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2153526379
- Cited by
- 314
- References
- 58
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.